Is dextromethorphan safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dextromethorphan Safety in Pregnancy

Dextromethorphan is safe to use during pregnancy for short-term symptomatic relief of cough, with no evidence of increased risk for birth defects above the baseline rate of 1-3%. 1, 2

Evidence Supporting Safety

The FDA drug label advises pregnant women to "ask a health professional before use" 3, which is standard precautionary language for over-the-counter medications. However, the research evidence strongly supports safety:

Human Studies Show No Teratogenic Risk

Two well-designed controlled studies directly examined dextromethorphan safety in pregnancy:

  • A controlled study of 184 pregnant women (128 used dextromethorphan in the first trimester) found only 2.3% major malformations among exposed infants compared to 2.8% in controls—both within the expected baseline rate of 1-3% 1

  • A large case-control epidemiologic analysis using logistic regression found no association between prenatal dextromethorphan exposure and neural tube defects, congenital heart defects, or other birth defects 2

Animal Study Concerns Are Not Applicable

Early concerns arose from a chick embryo study suggesting neural tube defects. However, chick embryos are not a valid model for human teratogenicity and were abandoned for this purpose over 30 years ago 4. The extrapolation from chickens to humans was inappropriate and created unnecessary public concern.

Clinical Use Recommendations

When to Use

  • For acute cough lasting ≤3 weeks associated with upper respiratory infections or acute bronchitis 5
  • Dextromethorphan provides short-term symptomatic relief, though efficacy is limited (typically <20% cough suppression in URI) 6

Dosing Considerations

  • Standard adult dosing applies (30 mg dextromethorphan hydrobromide equivalent per 5 mL) 3
  • Use for short-term relief only (discontinue if cough persists >7 days) 3

Important Contraindications

Do not use if the patient is taking or has taken within 2 weeks:

  • MAO inhibitors (for depression, psychiatric conditions, or Parkinson's disease) 3

Common Pitfalls to Avoid

  • The drug contains sodium metabisulfite, which may cause allergic reactions in sulfite-sensitive individuals 3
  • Avoid in chronic cough associated with smoking, asthma, or emphysema 3
  • Avoid if cough produces excessive phlegm 3

Real-World Context

Dextromethorphan is one of the most commonly used over-the-counter medications during pregnancy, with usage rates of at least 15% among pregnant women, and use actually increases during pregnancy compared to before pregnancy 7. This widespread use without corresponding increases in birth defects further supports its safety profile 8.

The ACCP guidelines acknowledge that antitussive agents like dextromethorphan "are occasionally useful and can be offered for short-term symptomatic relief of coughing" in acute bronchitis, though the benefit is characterized as "small/weak" 5. The limited efficacy should be weighed against the well-established safety profile when counseling pregnant patients.

Related Questions

Can a pregnant woman in her first trimester safely use dextromethorphan for cough, and what precautions or alternative treatments should be considered?
What are the safety considerations and dosage guidelines for using dexomethorphan in pregnant women?
How should dextromethorphan be administered?
What dose in milliliters of dextromethorphan oral suspension (30 mg per 5 mL) should be administered to a geriatric patient (age ≥ 65 years)?
What is the appropriate dose of dextromethorphan as a cough suppressant for a 6‑year‑old child weighing 22 kg?
What is the differential diagnosis for new‑onset absence seizures in a 57‑year‑old man with diabetes who is currently normoglycemic and has normal laboratory studies?
Is it safe to initiate an amphetamine/dextroamphetamine stimulant in a patient who has been taking sertraline 30 mg daily for many years?
Which biologic agents are recommended for patients with moderate-to-severe asthma uncontrolled on high-dose inhaled corticosteroid/long-acting β2-agonist therapy, based on allergic, eosinophilic, or type‑2 inflammatory phenotypes?
What is the recommended starting dose and titration plan for Adderall (mixed amphetamine salts) for an adult patient already taking sertraline 30 mg daily?
What is the physiology of urea production, renal handling, and its role in urine concentration?
What is the step‑by‑step approach and timing for diagnosing insulin resistance in a reproductive‑age woman with polycystic ovary syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.